Alkermes (ALKS) Deferred Taxes (2011 - 2026)
Alkermes (ALKS) posted quarterly Deferred Taxes of $9.1 million for Q2 2026, up 367.21% year-over-year from $1.9 million in Q2 2025, and up 203.61% quarter-over-quarter from -$8.8 million in Q1 2026.
Alkermes (ALKS) Deferred Taxes (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Deferred Taxes for 16 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Deferred Taxes rose 367.21% year-over-year to $9.1 million; the TTM figure through Jun 2026 stood at $28.3 million (up 58.14% YoY), while the FY2024 annual figure was $40.5 million, up 140.56% from the prior year.
- Deferred Taxes improved to $9.1 million in Q2 2026 per ALKS's latest filing, from -$8.8 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $31.4 million in Q3 2025 and bottomed at -$52.5 million in Q4 2023.
- Historically, Deferred Taxes has averaged -$3.6 million across 5 years, with a median of -$2.0 million in 2023.
- Annual changes were most pronounced in 2022 — Deferred Taxes tumbled 657.58% — and 2024, when it jumped 803.42%.
- Alkermes' Deferred Taxes stood at $21.3 million in 2022, then sank by 346.81% to -$52.5 million in 2023, then jumped by 115.63% to $8.2 million in 2024, then surged by 282.43% to $31.4 million in 2025, then tumbled by 71.0% to $9.1 million in 2026.
- Business Quant data shows ALKS's Deferred Taxes at $9.1 million in Q2 2026, -$8.8 million in Q1 2026, and $31.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 9.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.10 Mn |
| Mar 31, 2026 | -8.79 Mn |
| Sep 30, 2025 | 31.39 Mn |
| Jun 30, 2025 | -3.41 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 8.21 Mn |
| Sep 30, 2024 | 10.59 Mn |
| Jun 30, 2024 | 14.21 Mn |
| Mar 31, 2024 | 7.52 Mn |
| Dec 31, 2023 | -52.52 Mn |
| Sep 30, 2023 | -9.25 Mn |
| Jun 30, 2023 | -2.02 Mn |
| Mar 31, 2023 | -36.12 Mn |
| Dec 31, 2022 | 21.28 Mn |
| Sep 30, 2022 | -13.26 Mn |
| Jun 30, 2022 | -11.51 Mn |
| Mar 31, 2022 | -29.30 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | -8.79 Mn |
| Jun 30, 2021 | 5.55 Mn |